Heplisav-b 20 MCG/0.5 ML syrng 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV7Z3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $92,412
Award facts
- Contract value 100% obligated
- $92,412.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $92,412.22 to AmerisourceBergen Drug Corp for the supply of HEPLISAV-B 20 microgram/0.5 milliliter syringes. The contract, issued on January 28, 2026, with completion targeted for January 29, 2026, utilizes firm fixed-price pricing and carries no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
HEPLISAV-B is a hepatitis B vaccine, and this procurement supports the federal government's medical supply chain requirements for military treatment facilities and related defense health programs. AmerisourceBergen's role as a pharmaceutical prime vendor demonstrates its established capability to efficiently fulfill government contracts for essential medical commodities. The non-set-aside, competitively awarded nature of this delivery order, consistent with the company's broader federal contract portfolio, reflects AmerisourceBergen's qualification to meet federal procurement standards across diverse therapeutic domains and medical supply categories.
Quick answers
Who was awarded contract SPE2DR26FV7Z3?
SPE2DR26FV7Z3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FV7Z3 worth?
The government has obligated $92,412 on SPE2DR26FV7Z3.
Is contract SPE2DR26FV7Z3 an order under another contract?
Yes. SPE2DR26FV7Z3 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV7Z3 competed?
The extent of competition for SPE2DR26FV7Z3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award